About Insmed Incorporated

Insmed Incorporated (NASDAQ: INSM) is a Healthcare company (Biotechnology) with a market capitalization of $20.5B. Its Maz Rating is 2.61 out of 5 (C+, Hold), ranked against the other companies in its sector.

Factor scores: Valuation 1.75, Growth 4.70, Profitability 2.97, Financial Health 2.67, Momentum 2.52 (as of 2026-10-16).

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

CEO

William H. Lewis

Employees

1,664

IPO date

2000-06-01